Spotlight

Mar 01, 2024

Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals

Read more

Jul 11, 2023

Amyloidosis now a hot topic in cardiac imaging due to new drug treatment

July 11, 2023 | Cardiovascular Business For years, cardiac amyloidosis was a rare and often fatal disease that had no treatment, so it was not front and center in…

Read more

A vision toward a more holistic approach to care in hereditary ATTR amyloidosis

Read more

The Orphan Drug Act Turns 40: NORD Celebrates Its Impact on Rare Diseases

Read more

Health System First in Nation to Offer Treatment for Hereditary Amyloidosis

Read more

Stem Cell Transplantation Produces Prolonged Survival With Improved Safety in Patients With AL Amyloidosis

Read more

Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran

Read more

Gene Editing Offers Hope for Progressive Cardiomyopathy Due to Amyloidosis

Read more

Veterans and AL Amyloidosis

Read more

The Coverage Battle Continues for Veterans With Transthyretin Amyloidosis

Read more